Vector and Cell Line Engineering Technologies Toward Recombinant Protein Expression in Mammalian Cell Lines

Area of Science:

• Biotechnology
• Biopharmaceutical Manufacturing
• Molecular Biology

Background:

• The global biopharmaceutical market is rapidly expanding, underscoring the importance of efficient recombinant protein production.
• Optimizations in upstream and downstream processes have been ongoing since the 1980s.
• Mammalian cell lines are critical for manufacturing over 50% of approved therapeutic proteins.

Purpose of the Study:

• To review current approaches and developments in vector and cell line engineering technologies.
• To focus on strategies enhancing recombinant protein production in mammalian cell cultures.
• To discuss the significance of these technologies in the biopharmaceutical industry.

Main Methods:

• Expression vector engineering, including DNA opening elements and targeted gene integration.
• Cell line engineering for the isolation of high-producing clones.
• Analysis of recent advancements in mammalian cell culture techniques.

Main Results:

• Expression vector engineering offers promising strategies for enhancing protein yield.
• Cell line engineering facilitates the isolation of superior producing cell clones.
• These combined approaches contribute to more efficient biopharmaceutical manufacturing.

Conclusions:

• Vector and cell line engineering are pivotal for advancing recombinant protein production.
• Continued innovation in these areas is essential for the growing biopharmaceutical sector.
• Optimized mammalian cell culture technologies are key to meeting market demands.